These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 7904078)
1. [Neurotransmitter-receptor-imaging]. Cordes M; Hierholzer J; Nikolai-Beyer K Radiologe; 1993 Nov; 33(11):612-9. PubMed ID: 7904078 [TBL] [Abstract][Full Text] [Related]
2. Applications of neuroreceptor imaging to psychiatry research. Smith GS; Koppel J; Goldberg S Psychopharmacol Bull; 2003; 37(4):26-65. PubMed ID: 15131516 [TBL] [Abstract][Full Text] [Related]
3. Brain radioligands--state of the art and new trends. Halldin C; Gulyás B; Langer O; Farde L Q J Nucl Med; 2001 Jun; 45(2):139-52. PubMed ID: 11476163 [TBL] [Abstract][Full Text] [Related]
4. Vulnerability of positron emission tomography radiotracers to endogenous competition. New insights. Laruelle M; Huang Y Q J Nucl Med; 2001 Jun; 45(2):124-38. PubMed ID: 11476162 [TBL] [Abstract][Full Text] [Related]
5. An introduction to PET and SPECT neuroreceptor quantification models. Ichise M; Meyer JH; Yonekura Y J Nucl Med; 2001 May; 42(5):755-63. PubMed ID: 11337572 [TBL] [Abstract][Full Text] [Related]
6. [Receptor occupancy and antipsychotic drug action measured by PET and SPECT]. Okubo Y; Suhara T Seishin Shinkeigaku Zasshi; 2001; 103(4):329-40. PubMed ID: 11392846 [TBL] [Abstract][Full Text] [Related]
7. [The receptor binding study in vivo]. Inoue O; Kobayashi K Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Aug; 14(4):215-25. PubMed ID: 7975926 [TBL] [Abstract][Full Text] [Related]
8. Stereoselective neuroimaging in vivo. Smith DF; Jakobsen S Eur Neuropsychopharmacol; 2007 Jul; 17(8):507-22. PubMed ID: 17368004 [TBL] [Abstract][Full Text] [Related]
10. [Strategy for development of imaging biomarkers]. Ishiwata K Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Apr; 29(2):67-71. PubMed ID: 19562944 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic considerations in the PET and SPECT evaluation of CNS receptors. Mazière B; Delforge J Q J Nucl Med; 1997 Jun; 41(2):119-26. PubMed ID: 9203851 [TBL] [Abstract][Full Text] [Related]
12. [PET and SPECT in Parkinson's disease]. Blesa R Rev Neurol; 1997 Aug; 25 Suppl 2():S147-50. PubMed ID: 9280681 [TBL] [Abstract][Full Text] [Related]
13. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease. Horger M; Bares R Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146 [TBL] [Abstract][Full Text] [Related]
14. Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol. Kühl HP; Lipke CS; Krombach GA; Katoh M; Battenberg TF; Nowak B; Heussen N; Buecker A; Schaefer WM Eur Heart J; 2006 Apr; 27(7):846-53. PubMed ID: 16434414 [TBL] [Abstract][Full Text] [Related]
15. Molecular imaging of gene expression and protein function in vivo with PET and SPECT. Sharma V; Luker GD; Piwnica-Worms D J Magn Reson Imaging; 2002 Oct; 16(4):336-51. PubMed ID: 12353250 [TBL] [Abstract][Full Text] [Related]
16. The future of SPECT in a time of PET. Jansen FP; Vanderheyden JL Nucl Med Biol; 2007 Oct; 34(7):733-5. PubMed ID: 17921025 [TBL] [Abstract][Full Text] [Related]
17. [Study on neuroreceptor imaging with radionuclide tracing in vivo]. Wang RF; Liu M Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 39(5):550-4. PubMed ID: 17940579 [TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography for quantitative in vivo studies of neurotransmitter kinetics: a critical evaluation. Greitz T Adv Biochem Psychopharmacol; 1984; 39():69-78. PubMed ID: 6147069 [No Abstract] [Full Text] [Related]
20. In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands. Kegeles LS; Mann JJ Neuropsychopharmacology; 1997 Nov; 17(5):293-307. PubMed ID: 9348545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]